ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 745103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 745103; 2) Community: the network communities that were significantly associated with the response to NSC 745103; 3) Molecule: the relationships between components within communities and NSC 745103; 4) MDR: the compounds that were significantly associated with the NSC 745103.

NSC Compound Enrichment Correlation
NSC 745957 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide 0.0162638908166157 -0.10365549
NSC 754241 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.0162638908166157 -0.0046753659
NSC 756471 SB-732941 0.0162638908166157 0.088894474
NSC 84145 Null 0.0162638908166157 -0.026620672
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0163859626459253 -0.064682801
NSC 685470 Null 0.0163859626459253 0.0015462211
NSC 695323 Null 0.0163859626459253 -0.089171868
NSC 217697 Quinoline, 6,6'-methylenebis[1,2-dihydro-2,2,4-trimethyl]- 0.0171490505199913 -0.15865638
NSC 270057 Hydroxypristimerin 0.0171490505199913 -0.098474871
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0171490505199913 -0.15272827
Total:60  Current:16    [First] [Prev] [Next] [Last]